Apollo Endosurgery Inc.

NASDAQ: APEN · Real-Time Price · USD
10.00
0.00 (0.00%)
At close: Apr 03, 2023, 10:00 PM

Apollo Endosurgery Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-39.84M -40.69M -35.9M -28.5M -24.68M -17.78M -13.72M -16.96M
Depreciation & Amortization
2.97M 3M 2.98M 3.07M 3.23M 3.39M 3.56M 3.68M
Stock-Based Compensation
6.78M 5.07M 3.21M 1.56M n/a n/a n/a n/a
Other Working Capital
-433K 5.23M 3.57M 4.05M 4.1M 1.37M -233K -7.28M
Other Non-Cash Items
5.77M 9.97M 6.46M 194K -100K -2.44M -3.52M 656K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-6.94M -4.24M -2.7M -824K 710K -1.47M -4.69M -8.67M
Operating Cash Flow
-31.26M -25.3M -22.81M -18.83M -14.45M -12.91M -13.95M -18.86M
Capital Expenditures
-2.75M -2.73M -1.89M -1.71M -1.46M -1.04M -850K -609K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-84K 2.93M 2.93M 2.93M 2.94M 1.92M 1.92M 1.92M
Investing Cash Flow
-2.75M 289K 1.13M 1.31M 1.56M 957K 1.15M 1.39M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
349K 65.21M 66.49M 67.55M 67.58M 2.14M 24.08M 25.88M
Financial Cash Flow
349K 65.21M 66.49M 67.55M 67.58M 2.14M 24.08M 25.88M
Net Cash Flow
-33.8M 39.44M 44.5M 50.09M 54.61M -9.72M 11.53M 8.61M
Free Cash Flow
-34.01M -28.03M -24.69M -20.54M -15.91M -13.95M -14.8M -19.47M